University of Montana Research Could Provide Effective Treatment for Stroke and Traumatic Brain Injury - Sinapis Pharma
Reader Comments
| December 14, 2009 |
If Dave Poulsen’s research gets approval from federal regulators for medical use, Poulsen and his company Sinapis Pharma http://www.sinapispharma.com/ and his employer, the University of Montana, stand to make a lot of money on meth.
That’s right.
Poulsen’s unique methamphetamine application, which he co-developed with Nick Chandler, a former Missoula neurosurgeon, could generate millions in royalty payments for UM.
More important, this drug deal could save the lives of stroke victims – there are some 800,000 each year in this country alone – and dramatically improve the quality of life for those individuals, and also of people who suffer traumatic brain injuries.
Poulsen said he’s so confident about his research findings that “I know if I ever had a stroke or traumatic brain injury, I’d want to be treated with this stuff.”
....
All the promise and all the talent for turning academic exploration into profit are already in place at UM, said new Tech Transfer officer, Joe Fanguy http://www.umt.edu/research/techtran ... mber%202009 , who at age 32 is a scientist-inventor, and most recently served as assistant director of Mississippi State University’s Office of Technology.
The challenge, however, is to inspire and create a culture at UM that embraces the notion.
By BETSY COHEN of the Missoulian
Full Story: http://missoulian.com/news/local/art ... c002e0.html
***
University of Montana Spinoff, Sinapis Pharma, Closes Series 'A' Financing http://matr.net/article-36872.html
University of Montana Office of Technology Transfer http://www.umt.edu/research/techtran ... mber%202009
Montana State University Office of Technology Transfer: http://www.montana.edu/wwwvr/tto/index.html
Reader Comments:
|
The revitalization of tech transfer efforts at the University of Montana is a bellweather event but future success will take the efforts of all of Montana. Entrepreneurs, Angels, VC's, business professionals are all needed to assist and nurture the technology into the world of commercial success. I encourage anyone who has an interest in working with world class research commercialization opportunities to contact Joe Fanguy at the University of Montana and learn more about the possibilities. Joe.Fanguy (at) mso.umt.edu (406) 243-0211 --Russ
|
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

